Back to Top Skip to main content Skip to sub-navigation

New Travis AFB patient transport system supports COVID fight

Image of Soldiers in masks pushing a piece of equipment. U.S. Airmen assigned to the 60th Aerial Port and 21st Airlift Squadrons push a Negatively Pressurized Conex into a C-17 Globemaster III at Travis Air Force Base, California, Aug. 5, 2020. The NPC is certified for use on the C-17, and testing and certification is underway for use on the C-5M Super Galaxy. (U.S. Air Force photo by Lan Kim)

Recommended Content:

Coronavirus & the MHS Response

TRAVIS AIR FORCE BASE, California -- Travis Air Force Base gained a new isolated containment chamber Aug. 5 that can safely transport up to 24 walking patients, or eight patients on a stretcher with infectious diseases, such as the novel coronavirus, aboard an aircraft.

The unit, called a Negatively Pressurized Conex, is the third of its kind, with the first two already at Joint Base Charleston, South Carolina, and Ramstein Air Base, Germany.

Earlier this year, the Department of Defense and Air Force developed and procured the NPC in less than 30 days in response to a U.S. Transportation Joint Urgent Operational Need to transport COVID-19 patients.

Upon its arrival to Travis AFB, an NPC program manager and deputy program manager from the Air Force Life Cycle Management Center’s Air Force Chemical, Biological, Radiological, and Nuclear Defense Systems Branch, or AFLCMC/WNU, inspected the conex. They also oversaw transfer of the NPC from Delta Flight Products in Atlanta, Georgia, where it was manufactured, to the cargo bay of a Travis AFB C-17 Globemaster III staged to support alert aeromedical evacuation missions.

“We were with the NPC as it was being produced,” said U.S. Air Force Capt. Alexis Todaro, AFLCMC/WNU NPC program manager. “We did both inspections, as well as functional checks, to make sure the asset was performing and everything was included as contracted. We followed it to Travis and made sure the offload went smoothly. Next, we’ll work with the aeromedical team that is here training and go over a few of the features they may or may not be familiar with.”

The first operational use of an NPC took place July 1, moving 12 patients from the U.S. Central Command area of responsibility to Ramstein AB. Since then, it has undergone several iterations of testing and user feedback, Todaro said.

Compared to its predecessors, the NPC that arrived at Travis has notably bigger doors and windows to allow for better visual communication, as well as seats with increased safety factor ratings, Todaro said.

The new system will amplify Travis AFB’s current infectious disease patient transport capabilities, which consist of eight Transport Isolation Systems.

The TIS, which has been the primary means for the Air Force to transport COVID-19 patients since the onset of the coronavirus pandemic, is only capable of transporting up to four patients.

The NPC has a greater capacity of transporting up to 30 aircraft passengers and multiple configurations to accommodate combinations of ambulatory and litter patients, as dictated by the mission, said 1st Lt. Donald Wiegner, AFLCMC/WNU NPC deputy program manager.

Due to its capacity, the NPC will become the primary transport option of COVID-19 patients within the U.S. Indo-Pacific Command area of responsibility, Todaro said.

“The Indo-Pacific fight against COVID-19 hot spots is constantly changing throughout AORs,” said Wiegner. “With the limited NPC assets available at this time, it is a strategic advantage to posture at Travis AFB as a central logistical hub for NPCs to run missions throughout the Indo-Pacific as needed to evacuate soldiers, sailors, Marines, and airmen so they can get the medical care they need.”

As of Aug. 7, AMC’s NPC and TIS bio-containment units have transported 190 patients total on 30 separate aeromedical evacuation missions since the first operational use of the TIS April 10.

You also may be interested in...

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

Establishes the DHA's procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits for enduring COVID-19 support.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

Supplemental Guidance for Providing DOD Coronavirus Disease 2019 Vaccines to DOD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

Showing results 1 - 12 Page 1 of 1
Refine your search
Last Updated: August 15, 2022

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.